Some of the content on this page has been created using generative AI.
What is it about?
This research discusses a study evaluating the use of long-term MRI findings, PSA density, and prior biopsy results to potentially reduce the need for biopsies in prostate cancer patients on active surveillance (AS) for 5+ years. The study analyzed 221 men with Grade Group 1 prostate cancer who underwent a 6-year MRI and biopsy. Results showed that 22% were reclassified to GG ≥2, and while an unsuspicious MRI alone was not sufficient to omit the 6-year biopsy, combining MRI findings with PSA density and prior negative biopsies showed promise. The study concluded that scheduled AS biopsies should still be performed for patients with favorable imaging and clinical characteristics, but further research is needed to validate the findings in larger cohorts and determine the oncological risk of GG ≥2 cancers not visible on MRI.
Featured Image
Why is it important?
This research is significant because it investigates the potential to reduce the frequency of biopsies in prostate cancer patients undergoing active surveillance (AS). Biopsies are invasive procedures that can cause discomfort and complications for patients, so finding ways to safely reduce their frequency could improve patient quality of life and increase compliance with AS protocols. The study explores the use of magnetic resonance imaging (MRI) findings, prostate-specific antigen (PSA) density, and prior biopsy results to predict the risk of cancer progression, which could lead to more personalized and less invasive monitoring strategies for prostate cancer patients. Key Takeaways: 1. MRI Limitations: The study found that an unsuspicious MRI at 6 years of active surveillance is not sufficient on its own to safely omit a scheduled biopsy, as the risk of missing Grade Group ≥2 cancer remains too high (12-14%). 2. Combination Approach: Combining MRI findings with PSA density and prior negative biopsy results shows promise in identifying patients at lower risk of cancer progression, potentially allowing for less frequent biopsies in select cases. 3. Further Research Needed: The study emphasizes the need for validation of these findings in larger cohorts before implementing changes to clinical practice, highlighting the importance of balancing the desire to reduce invasive procedures with the need to accurately detect cancer progression.
AI notice
Read the Original
This page is a summary of: Magnetic resonance imaging for long‐term active surveillance biopsy decision‐making, BJU International, May 2025, Wiley,
DOI: 10.1111/bju.16798.
You can read the full text:
Contributors
Be the first to contribute to this page







